09.01.2013 Views

2 - TI Pharma

2 - TI Pharma

2 - TI Pharma

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Chapter 7 GLP-1 prevents glucocorticoid-related metabolic effects<br />

Taken together, this study provides evidence that the GLP-1 RA exenatide may prevent<br />

prednisolone-induced glucose intolerance and restore islet-cell functional balance. Longterm<br />

studies in relevant populations should explore the potential of GLP-1 RA treatment as a<br />

novel strategy to prevent steroid diabetes.<br />

Acknowledgments and Funding: The authors express their gratitude to Mark Fineman<br />

(Amylin <strong>Pharma</strong>ceuticals) for the determination of exenatide plasma levels. Drs. Daniël<br />

van Raalte and Drs. Margot Linssen are supported by the Dutch Top Institute <strong>Pharma</strong> (<strong>TI</strong>P)<br />

grant T1-106. Drs. Renate van Genugten is supported by the EFSD/MSD Clinical Research<br />

Programme 2008. Dr. D. Margriet Ouwens is supported by the Ministry of Innovation, Science,<br />

Research and Technology of the German state of North-Rhine Westphalia, and the EU European<br />

Cooperation in the field of Scientific and Technical Research (COST) Action BM0602.<br />

144

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!